U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) shares hit a new 52-week low on Monday . The stock traded as low as $77.97 and last traded at $78.73, with a volume of 5546 shares. The stock had previously closed at $81.05.
A number of research analysts have issued reports on the stock. Bank of America reaffirmed a "neutral" rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st. Finally, Barrington Research reiterated an "outperform" rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research report on Friday, September 20th.
View Our Latest Analysis on U.S. Physical Therapy
The stock has a market cap of $1.18 billion, a price-to-earnings ratio of 64.89, a PEG ratio of 4.03 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The business has a fifty day simple moving average of $85.93 and a 200 day simple moving average of $95.30.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The firm had revenue of $167.19 million for the quarter, compared to analysts' expectations of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.76 EPS. As a group, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were given a $0.44 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.24%. U.S. Physical Therapy's payout ratio is currently 143.09%.
In related news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares of the company's stock, valued at approximately $580,635. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, Director Kathleen A. Gilmartin bought 2,000 shares of the business's stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the purchase, the director now owns 18,904 shares in the company, valued at $1,627,445.36. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares of the company's stock, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.70% of the company's stock.
Several institutional investors and hedge funds have recently bought and sold shares of USPH. Canada Pension Plan Investment Board bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $28,000. Innealta Capital LLC acquired a new position in U.S. Physical Therapy in the second quarter worth $30,000. Quest Partners LLC increased its stake in U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company's stock valued at $32,000 after purchasing an additional 337 shares during the last quarter. Northwest Bank & Trust Co acquired a new stake in shares of U.S. Physical Therapy during the fourth quarter worth $37,000. Finally, Quarry LP lifted its position in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company's stock worth $48,000 after buying an additional 478 shares during the last quarter.
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.